Adagio Medical to Present at the Stifel 2024 Healthcare Conference

LAGUNA HILLS, Calif.--(BUSINESS WIRE)-- Adagio Medical Holdings, Inc. (Nasdaq: ADGM; the “Company”), a leading innovator in catheter ablation technologies for treatment of cardiac arrhythmias, today announced that its CEO & President, Olav Bergheim, will present at the Stifel 2024 Healthcare Conference on Monday, November 18, at 9:45 a.m. Eastern Time in New York, NY at the Lotte New York Palace Hotel.

A live audio webcast and replay of the presentation may be accessed on the “Investors” section of the company’s website at: https://www.adagiomedical.com/.

About Adagio Medical

Adagio Medical is an early commercial stage medical device company located in Laguna Hills, California focusing on developing innovative cryoablation technologies that create contiguous, transmural lesions to treat cardiac arrhythmias, including paroxysmal and persistent atrial fibrillation, atrial flutter, and ventricular tachycardia.

View source version on businesswire.com: https://www.businesswire.com/news/home/20241104375402/en/

Media Contact
Ilya Grigorov
Vice President, Global Marketing and Product Management of Adagio Medical, Inc.
[email protected]

Investor Contact
[email protected]

Source: Adagio Medical Holdings, Inc.

You May Also Be Interested In

• Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• Bitcoin Price Prediction 2026: Could it Hit $150k By Mid 2027 While Apeing is Heating Up As Next Crypto to Explode
• Inhibrx To Host Webcast Presentation to Provide Primary Endpoint Results for INBRX-106 Phase 2 First-Line HNSCC Study